Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-05-12 @ 4:51 AM
Study NCT ID:
NCT05006534
Status:
COMPLETED
Last Update Posted:
2021-08-16
First Post:
2021-08-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Polatuzumab Vedotin in Patients With Relapsed and Refractory Diffuse Large B Cell Lymphoma
Sponsor:
National Taiwan University Hospital
Organization: